| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZF9sd1dvT1Z4WTJ5ODJTbGhBTjJnb1ZGb3NLR3l5M1U0dnlTNWtmOEtDVVBxeGVjN1lna2RGanN4QVFnblMwaGR6UnphLVk3aE5SM0JJRWduZURaaVlfSjNMTnY5NDhpZzk1U0ROUWktVWotT2FZUi1BakJDeExvUW5XWFJnOF9NVlQydzZBcWh0OVE?oc=5","as_of":"2026-04-10T17:21:18.772571+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZF9sd1dvT1Z4WTJ5ODJTbGhBTjJnb1ZGb3NLR3l5M1U0dnlTNWtmOEtDVVBxeGVjN1lna2RGanN4QVFnblMwaGR6UnphLVk3aE5SM0JJRWduZURaaVlfSjNMTnY5NDhpZzk1U0ROUWktVWotT2FZUi1BakJDeExvUW5XWFJnOF9NVlQydzZBcWh0OVE?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_b63cb5b3f2fb2618","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-11T21:05:57.588281+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZF9sd1dvT1Z4WTJ5ODJTbGhBTjJnb1ZGb3NLR3l5M1U0dnlTNWtmOEtDVVBxeGVjN1lna2RGanN4QVFnblMwaGR6UnphLVk3aE5SM0JJRWduZURaaVlfSjNMTnY5NDhpZzk1U0ROUWktVWotT2FZUi1BakJDeExvUW5XWFJnOF9NVlQydzZBcWh0OVE?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZF9sd1dvT1Z4WTJ5ODJTbGhBTjJnb1ZGb3NLR3l5M1U0dnlTNWtmOEtDVVBxeGVjN1lna2RGanN4QVFnblMwaGR6UnphLVk3aE5SM0JJRWduZURaaVlfSjNMTnY5NDhpZzk1U0ROUWktVWotT2FZUi1BakJDeExvUW5XWFJnOF9NVlQydzZBcWh0OVE?oc=5","source_event_id":"evt_4d95829b1430","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"416424b051f74f1f","kind":"ipo_calendar","published_at":"2026-04-10T16:03:38+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.6,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Oricell","relevance":"primary","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["No article text is provided, so the megaround size, investors, timing/date of the close, and use of proceeds are unknown.","No information is provided on whether Oricell is publicly listed or the expected IPO timeline.","No details are provided on the specific CAR-T program(s), trial stage, or regulatory status."],"key_facts":["The signal headline states that Oricell closed a \u201cpre-IPO\u201d megaround.","The stated aim is to target CAR-T therapies at solid tumors."],"numeric_claims":[],"primary_claim":"Oricell closed a \u201cpre-IPO\u201d megaround to aim CAR-T at solid tumors.","relevance_score":0.55,"sentiment":"neutral","source_quality":"unknown","summary":"Oricell has closed a \u201cpre-IPO\u201d megaround, with the stated goal of developing CAR-T therapies for solid tumors.","topics":["pre-IPO funding","CAR-T","solid tumors","biopharma","Oricell"]},"source":"BioPharma Dive","source_domain":"gstatic.com","summary":"Oricell closes a \u2018pre-IPO\u2019 megaround to aim CAR-T at solid tumors BioPharma Dive","tickers":[],"title":"Oricell closes a \u2018pre-IPO\u2019 megaround to aim CAR-T at solid tumors - BioPharma Dive","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}... |